Literature DB >> 29173167

A Systematic Review on the Sinomenine Derivatives.

Jian Tang1,2, Aun Raza1, Jian Chen1, Huaxi Xu2.   

Abstract

Sinomenine is one of the most widely known alkaloids owing to different therapeutic properties including anti-inflammatory and immunosuppressive activities, as well as the potency in neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Sinomenine has been studied as a potential anti-inflammatory agent through appropriate structural modifications. Recently, a number of such approaches have been attempted in various laboratories with great success. Several series of derivatives have been synthesized with changes at rings A, B, C and D. Herein, we present an up to date review of modifications and bioactivities of important modified derivatives. These studies offer interesting knowledge on the bioactivity and structural specificity of sinomenine, providing better understanding of the structure-activity relationships (SAR) between designing and development of sinomenine derivative with better therapeutic and lower side effects. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Anti-inflammatory; immunosuppressive; neurodegenerative disorders; sinomenine derivatives; structural modification; structure-activity relationship.

Mesh:

Substances:

Year:  2018        PMID: 29173167     DOI: 10.2174/1389557517666171123212557

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  10 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.

Authors:  Zahra Kiasalari; Siamak Afshin-Majd; Tourandokht Baluchnejadmojarad; Ensie Azadi-Ahmadabadi; Marzieh Fakour; Reihaneh Ghasemi-Tarie; Shahram Jalalzade-Ogvar; Vahid Khodashenas; Mahsa Tashakori-Miyanroudi; Mehrdad Roghani
Journal:  J Mol Neurosci       Date:  2020-08-19       Impact factor: 3.444

3.  Sinomenine Inhibits the Growth of Ovarian Cancer Cells Through the Suppression of Mitosis by Down-Regulating the Expression and the Activity of CDK1.

Authors:  Xiaoyan Qu; Bing Yu; Mengmei Zhu; Xiaomei Li; Lishan Ma; Chuyin Liu; Yixing Zhang; Zhongping Cheng
Journal:  Onco Targets Ther       Date:  2021-02-05       Impact factor: 4.147

4.  Sinomenine activation of Nrf2 signaling prevents inflammation and cerebral injury in a mouse model of ischemic stroke.

Authors:  Fangfang Bi; Yiyong Zhang; Wenbo Liu; Keliang Xie
Journal:  Exp Ther Med       Date:  2021-04-18       Impact factor: 2.447

5.  Qing-Luo-Yin Alleviated Experimental Arthritis in Rats by Disrupting Immune Feedback Between Inflammatory T Cells and Monocytes: Key Evidences from Its Effects on Immune Cell Phenotypes.

Authors:  Dan-Dan Wang; Xin-Yue Wu; Ji-Yang Dong; Xiu-Ping Cheng; Shao-Fei Gu; Opeyemi Joshua Olatunji; Yan Li; Jian Zuo
Journal:  J Inflamm Res       Date:  2021-12-30

6.  Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway.

Authors:  ManLi Yuan; Bei Zhao; Huaping Jia; Can Zhang; Xiaowen Zuo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression.

Authors:  Haili Xu; Jiayan Dong; Junhui Hou; Rui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-01       Impact factor: 2.629

8.  Design, Synthesis, Biological Evaluation and Silico Prediction of Novel Sinomenine Derivatives.

Authors:  Shoujie Li; Mingjie Gao; Xin Nian; Liyu Zhang; Jinjie Li; Dongmei Cui; Chen Zhang; Changqi Zhao
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

9.  Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity.

Authors:  Yingying Wang; Linlin Wu; Haiyan Cai; Hu Lei; Chun-Min Ma; Li Yang; Hanzhang Xu; Qi Zhu; Zhujun Yao; Yingli Wu
Journal:  Cell Death Dis       Date:  2018-10-25       Impact factor: 8.469

10.  The Effect of Acupoint Application of Sinomenine for Rheumatoid Arthritis Measured by Microdialysis and UPLC-MS/MS.

Authors:  Rui Wang; Jing Yang; Yuxuan Liu; Bixi Guan; Qun Feng; Yanhong Wang; Shaowa Lv; Zhixin Yang; Yongji Li
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-28       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.